Norleual-AngIV was used to inhibit HGF binding to the c-Met receptor, consequently blocking HGF-dependent signaling pathways involved in proliferation, invasion, and scattering
Contact Us Dihexa (PNB-0408) is a synthetic compound derived from angiotensin IV, studied for its proposed interactions with hepatocyte growth factor (HGF) signalling and MET receptor pathway modulation in experimental models
Dihexa 10mg Dihexa 10 mg is a laboratory-grade research peptide chemical designed for experimental investigation of hepatocyte growth factor (HGF)related signaling pathways
Each capsule delivers a precise 10 mg of pure DIHEXA in a convenient, stable oral capsule form
Taking 1 mL working solution as an example, add 100 L DMSO stock solution ( 25.0 mg/mL ) to 400 L PEG300 , and mix evenly
The high-dose Dihexa group was indistinguishable from vehicle controls across all testing days